Deciphera Pharmaceuticals, Inc. EBITDA Margin 2018-2024 | DCPH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Deciphera Pharmaceuticals, Inc. (DCPH) over the last 10 years. The current EBITDA margin for Deciphera Pharmaceuticals, Inc. as of March 31, 2024 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-03-31 | $0.17B | $-0.20B | -117.24% |
| 2023-12-31 | $0.16B | $-0.21B | -129.01% |
| 2023-09-30 | $0.15B | $-0.21B | -136.67% |
| 2023-06-30 | $0.14B | $-0.20B | -137.06% |
| 2023-03-31 | $0.14B | $-0.19B | -136.50% |
| 2022-12-31 | $0.13B | $-0.18B | -135.34% |
| 2022-09-30 | $0.12B | $-0.22B | -182.64% |
| 2022-06-30 | $0.11B | $-0.26B | -237.04% |
| 2022-03-31 | $0.10B | $-0.28B | -283.00% |
| 2021-12-31 | $0.10B | $-0.30B | -310.42% |
| 2021-09-30 | $0.09B | $-0.27B | -298.90% |
| 2021-06-30 | $0.08B | $-0.26B | -308.43% |
| 2021-03-31 | $0.07B | $-0.25B | -384.85% |
| 2020-12-31 | $0.04B | $-0.27B | -653.66% |
| 2020-03-31 | $0.03B | $-0.23B | -904.00% |
